Amalgamated Bank Palatin Technologies Inc Transaction History

Amalgamated Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$0.41 - $0.73 $14,445 - $25,720	-35,233 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$0.36 - $0.79 $544 - $1,195	-1,513 Reduced 4.12%	35,233 $15,000
Q3 2019 Nov 13, 2019	SELL	$0.78 - $1.09 $253 - $354	-325 Reduced 0.88%	36,746 $33,000
Q2 2019 Aug 14, 2019	BUY	$0.98 - $1.64 $5,727 - $9,584	5,844 Added 18.71%	37,071 $43,000
Q1 2019 May 15, 2019	BUY	$0.67 - $1.01 $707 - $1,066	1,056 Added 3.5%	31,227 $31,000
Q4 2018 Feb 15, 2019	BUY	$0.63 - $1.0 $11,448 - $18,173	18,173 Added 151.47%	30,171 $21,000
Q3 2018 Nov 14, 2018	SELL	$0.88 - $1.1 $15,042 - $18,803	-17,094 Reduced 58.76%	11,998 $12,000
Q2 2018 Jul 18, 2018	BUY	$0.91 - $1.45 $26,473 - $42,183	29,092 New	29,092 $28,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $7.15M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.